A. Schroer

A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists.

E. Kolibianakis, P. Devroey, A. Steirteghem, 2005, Human reproduction.

Metabolism of vitamin D3 in the placental tissue of normal and preeclampsia complicated pregnancies and premature births.

J. Reichrath, M. Friedrich, T. Cordes, 2007, Clinical and experimental obstetrics & gynecology.

Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany

M. Hund, D. Schlembach, A. Schroer, 2018, BMC Health Services Research.

Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study.

K. Diedrich, A. Schultze-Mosgau, G. Griesinger, 2007, Human reproduction.

Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol.

D. Hornung, K. Dafopoulos, K. Diedrich, 2005, Human reproduction.

Mid-cycle serum levels of endogenous LH are not associated with the likelihood of pregnancy in artificial frozen-thawed embryo transfer cycles without pituitary suppression.

E. Kolibianakis, K. Diedrich, G. Griesinger, 2007, Human Reproduction.